J&J
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey. The company is ranked No. 42 on the 2026 Fortune 500 list of the largest United States corporations. In 2026, the company was ranked 43rd in the Forbes Global 2000. Along with Microsoft, Johnson & Johnson is one of only two U.S.-based companies that has a prime credit rating of AAA from S&P Global.
Beyond's analysis on J&J
- — Johnson & Johnson's equity portfolio reveals its top‑performing holdings among 15 stake investments
- — J&J’s $5.5 billion talc settlement removes a major overhang but leaves lingering legal risk for the healthcare conglomerate
- — Johnson & Johnson agrees to $5.5 billion settlement to resolve talc‑related lawsuits
- — Johnson & Johnson’s $5.5 billion talc settlement removes a major earnings overhang and sets a precedent for mass‑tort resolutions in consumer health
Recent news mentioning J&J
- — Apollo and J&J Face a High-Stakes Orthopedics Deal
- — Apollo rumoured to be eyeing $20bn takeover of J&J’s orthopaedics business
- — J&J in talks to sell DePuy Synthes to Apollo for $20 billion
- — J&J Is In Talks to Sell Its Hips-and-Knees Business to Apollo for $20 Billion
- — Apollo Global Is Said in Talks to Acquire J&J’s Orthopedics Unit
- — Jim Cramer Picks J&J (JNJ) Over Eli Lilly (LLY) and Pfizer (PFE) Among These Healthcare Stocks